Search Results - "Spiriti, M A Aloe"

Histological recovery and gluten‐free diet adherence: a prospective 1‐year follow‐up study of adult patients with coeliac disease by Galli, G., Esposito, G., Lahner, E., Pilozzi, E., Corleto, V. D., Di Giulio, E., Aloe Spiriti, M. A., Annibale, B.

“…Summary Background Adequate gluten‐free diet (GFD) is the only treatment for coeliac disease (CD). However, no agreement has been reached on either how and…”
Get full text

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story by Bari, A., Marcheselli, L., Sacchi, S., Marcheselli, R., Pozzi, S., Ferri, P., Balleari, E., Musto, P., Neri, S., Aloe Spiriti, M.A., Cox, M.C.

“…Improved treatment have modified survival outcome in patients with diffuse large B-cell lymphoma (DLBCL) and altered the importance of previously recognized…”
Get full text

Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia by VANNELLA, L., ALOE SPIRITI, M. A., COZZA, G., TARDELLA, L., MONARCA, B., CUTERI, A., MOSCARINI, M., DELLE FAVE, G., ANNIBALE, B.

“…Summary Background  Iron‐deficiency anaemia (IDA) is common in premenopausal women and menorrhagia is often considered responsible. Aim  To evaluate…”
Get full text

Cutaneous manifestations of systemic non-Hodgkin lymphomas (NHL): study and review of literature by Carlesimo, M., Narcisi, A., Rossi, A., Saredi, I., Orsini, D., Pelliccia, S., Aloe Spiriti, M.A., Mari, E., Cox, M.C.

“…Systemic non‐Hodgkin lymphomas are often accompanied by cutaneous manifestations, which are not always looked out for. Nevertheless, these alterations can be…”
Get full text

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome by Spiriti, M A Aloe, Latagliata, R, Niscola, P, Cortelezzi, A, Francesconi, M, Ferrari, D, Volpe, E, Clavio, M, Grossi, A, Reyes, M Tambone, Musto, P, Mitra, M E, Azzarà, A, Pagnini, D, D'Arena, G, Spadano, A, Balleari, E, Pecorari, P, Capochiani, E, De Biasi, E, Perego, D, Monarca, B, Pisani, F, Scaramella, G, Petti, M C

“…This study evaluated the impact of a new epoetin alfa dosing regimen on quality of life (QOL), transfusion requirements, and hemoglobin (Hb) levels in 133…”
Get full text

Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron‐deficiency anaemia presentation by BACCINI, F., ALOE SPIRITI, M. A., VANNELLA, L., MONARCA, B., DELLE FAVE, G., ANNIBALE, B.

“…Summary Background  Most adults with coeliac disease have a subclinical form of the disease and iron‐deficiency anaemia may be the sole presenting symptom. Aim…”
Get full text

Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes by Gurnari, C., Latagliata, R., Buccisano, F., Piciocchi, A., Fenu, S., Mancini, S., Fianchi, L., Criscuolo, M., Sarlo, C., Romano, A., Falconi, G., Niscola, P., Di Veroli, A., Breccia, M., Piccioni, A., Aloe-Spiriti, M.A., Lo-Coco, F., Voso, M.T.

Get full text

High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias by PETTI, M. C, TAFURI, A, ALIMENA, G, MANDELLI, F, LATAGLIATA, R, ALOE SPIRITI, M. A, MONTEFUSCO, E, MANCINI, M, MELONI, G, PETRUCCI, M. T, SPADEA, A, REDI, R

“…The aim of the study was to evaluate the antileukemic effectiveness and toxicity of high-dose hydroxyurea (HHY) and to assess its acute toxicity. Between…”
Get full text

Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event by Petti, MC, Latagliata, R, Breccia, M, Alimena, G, Spadea, A, D'Andrea, M, Mancini, M, Aloe Spiriti, MA, Mandelli, F

“…Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, via Benevento 6, 00161 Rome, Italy. BACKGROUND AND OBJECTIVES: Spontaneous…”
Get full text

Melphalan treatment in patients with myelofibrosis with myeloid metaplasia by Petti, M. C., Latagliata, R., Spadea, T., Spadea, A., Montefusco, E., Aloe Spiriti, M. A., Avvisati, G., Breccia, M., Pescarmona, E., Mandelli, F.

“…Between January 1985 and December 1992, 104 consecutive patients with symptomatic myelofibrosis with myeloid metaplasia (MMM) [splenic enlargement > 5 cm…”
Get full text

A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders by Navarra, P., Aloe-Spiriti, M.A., Boccarini, F., Montefusco, E., Latagliata, R., Preziosi, P., Petti, M.C.

“…We have shown previously that the antitumor drug, hydroxyurea (HU) is able to induce dose-dependent increases in plasma corticosterone levels in the rat. The…”
Get full text

Polycythaemia vera and cerebral blood flow: a preliminary study with transcranial Doppler by Fiermonte, G, Aloe Spiriti, M A, Latagliata, R, Petti, M C, Giacomini, P

“…The purpose of this study has been to investigate by ultrasonographic methods the flow velocities of cerebral arteries because increased blood viscosity due to…”
Get more information

In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells by Aglietta, M, De Felice, L, Stacchini, A, Petti, M C, Bianchi, A C, Aloe Spiriti, M A, Sanavio, F, Apra, F, Piacibello, W, Stern, A C

“…Granulocyte-macrophage colony-stimulating factor, (GM-CSF) was given at 8 micrograms/kg daily by continuous i.v. infusion for 72 h to six patients with acute…”
Get more information

Ph-negative and bcr-negative atypical chronic myelogenous leukemia : biological features and clinical outcome by MONTEFUSCO, E, ALIMENA, G, LO COCO, F, DE CUIA, M. R, WANG, Y.-Z, ALOE SPIRITI, M. A, MANCINI, F, CEDRONE, M, MANCINI, M, MANDELLI, F

“…We report the clinical, hematologic, cytogenetic, and molecular characteristics of 13 patients with Philadelphia-negative (Ph-), bcr-negative atypical chronic…”
Get full text

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients by Visani, G, Finelli, C, Castelli, U, Petti, M C, Ricci, P, Vianelli, N, Gianni, L, Zuffa, E, Aloe Spiriti, M A, Latagliata, R

“…The prognostic value of 12 clinical and haematological parameters, recorded at diagnosis, in myelofibrosis with myeloid metaplasia (MMM) was retrospectively…”
Get more information

Thymopentin in the treatment of myelodysplastic syndromes by Latagliata, R, Petti, M C, Aloe Spiriti, M A, Tirindelli, M C, Fazi, P, De Gregoris, C, Mandelli, F

Get more information

Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferon by Petti, M C, Latagliata, R, Avvisati, G, Spiriti, M A, Montefusco, E, Spadea, A, Mandelli, F

“…Seventeen patients with high-risk myelodysplastic syndromes (HR-MDS) received lymphoblastoid-interferon alpha (Ly-IFN alpha) for 3 months at escalating doses…”
Get more information

Acute Myeloblastic Leukemia Secondary to Myelodysplasia (MDS-AML): A Comparison of Remission Induction with Three Drugs Versus Standard Two-Drugs Induction by Latagliata, R., Breccia, M., Pulsoni, A., Aloe Spiriti, M. A., D'elia, G. M., Spadea, A., Montefusco, E., Luzi, G., Betró, P., Petti, M. C.

“…To evaluate the addition of a third drug to standard induction chemotherapy in patients with MDS-AML, 23 patients (males/ females 13/10, median age 54.3 years,…”
Get full text

Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile? by Aloe Spiriti, M A, Petti, M C, Latagliata, R, Avvisati, G, De Gregoris, C, Proia, S, Fazi, P, Jaalouk, G, Mancini, M, Spadea, A

“…It has been recently demonstrated that erythropoietin increases the haemoglobin levels in anemia secondary to chronic renal failure. Moreover some recent…”
Get more information

Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim report by Aloe Spiriti, M A, Petti, M C, Latagliata, R, Avvisati, G, De Gregoris, C, Proia, S, Fazi, P, Jaalouk, G, Mancini, M, Spadea, A

“…It has recently been demonstrated that erythropoietin increases hemoglobin levels in anemia secondary to chronic renal failure. Some recent experiences have…”
Get more information